Hemodialysis Timing for Kidney Failure

(POD-ESKD Trial)

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Stanford University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of this clinical trial is to evaluate the feasibility of two different preoperative hemodialysis schedules for people with end-stage kidney disease (ESKD) who undergo surgical procedures. The main questions it aims to answer are:

Is it feasible to randomize participants with ESKD undergoing nonemergent surgical procedures to same-day hemodialysis versus no same-day hemodialysis?

Is it safe to randomize participants with ESKD undergoing nonemergent surgical procedures to same-day hemodialysis versus no same-day hemodialysis?

Researchers will compare the two hemodialysis schedules to see if the scheduling and safety profiles are the same.

Participants will:

Answer questions about their health up to 4 weeks before and 4 weeks after the surgical procedure.

Receive hemodialysis on the day of the surgical procedure or not, depending on the study treatment assignment.

Who Is on the Research Team?

VF

Vikram Fielding-Singh, MD, JD

Principal Investigator

Stanford University

Are You a Good Fit for This Trial?

This trial is for people with end-stage kidney disease (ESKD) who have been on a stable hemodialysis schedule for at least 90 days before their non-emergency surgery. They must be willing to follow the study's procedures and can't participate if they don't meet these requirements.

Inclusion Criteria

I have had a bypass surgery in my leg.
I have had an amputation below the hip.
I started hemodialysis more than 90 days before my scheduled surgery.
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Preoperative Assessment

Participants answer questions about their health up to 4 weeks before the surgical procedure

4 weeks

Treatment

Participants receive hemodialysis on the day of the surgical procedure or not, depending on the study treatment assignment

1 day

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessment of 30-day postoperative outcomes

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • No Same-Day Hemodialysis
  • Same-Day Hemodialysis

Trial Overview

The POD-ESKD Pilot Trial is testing whether it's feasible and safe to perform hemodialysis on the same day as surgery compared to not doing so. Participants will either receive hemodialysis on the day of their surgical procedure or they won't, based on random assignment.

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Active Control

Group I: Same-Day HemodialysisExperimental Treatment1 Intervention
Group II: No Same-Day HemodialysisActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Stanford University

Lead Sponsor

Trials
2,527
Recruited
17,430,000+

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Collaborator

Trials
2,513
Recruited
4,366,000+